Desensitization & Feedback - Cell Biology

A kinase activated by one hormone receptor phosphorylates a different receptor. This is:
Answer: Heterologous desensitization A kinase triggered by one receptor can phosphorylate other receptors, shutting them down too; that is heterologous desensitization. Homologous desensitization would involve the same receptor's own signaling causing its phosphorylation. The tempting wrong answer is homologous desensitization, but it applies only when the receptor that activates the kinase is the one inactivated.
A mutation disables an inducible inhibitor induced by a pathway's own activity. What directly follows?
Answer: Prolonged pathway activation If a pathway's own activity induces an inhibitor, that inhibitor normally shuts the pathway down after a response. Disabling it removes this negative feedback, so the pathway stays active longer. Complete desensitization is tempting because it sounds like loss of inhibition, but desensitization means reduced responsiveness, not sustained signaling.
Chronic exposure to high glucose levels causes pancreatic β-cells to show reduced insulin secretion response to subsequent glucose challenges. This occurs even when glucose-sensing machinery remains functional. Which mechanism most likely explains this desensitization?
Answer: Depletion of readily releasable insulin vesicle pools due to chronic stimulation demands When you encounter questions about cellular desensitization or reduced responsiveness despite functional sensing machinery, think about the physical limitations of the secretory process rather than the detection mechanisms. Pancreatic β-cells store insulin in two distinct pools: a readily releasable pool (RRP) of vesicles docked at the plasma membrane ready for immediate exocytosis, and a reserve pool that must be mobilized and processed before release. Under normal glucose stimulation, the RRP provides the rapid first-phase insulin response. However, chronic high glucose exposure continuously depletes this readily available pool faster than it can be replenished from reserve stores, even though glucose sensing remains intact. This creates a functional bottleneck where the cell "knows" glucose is present but lacks sufficient prepared vesicles for robust insulin secretion. Option A is incorrect because glucose transporters (GLUT2) in β-cells have high capacity and rarely saturate under physiological conditions. Option C misses the mark because ATP generation typically remains adequate - the problem isn't energy production but vesicle availability. Option D incorrectly suggests impaired depolarization, but the question states that glucose-sensing machinery (including the electrical response pathway) remains functional. The key distinction here is between sensing capability and secretory capacity. While the cell can still detect and respond to glucose, its physical ability to release insulin becomes limited by vesicle depletion. Study tip: For β-cell physiology questions, remember that insulin secretion depends on both glucose detection AND adequate vesicle pools - chronic stimulation often depletes the latter while leaving the former intact.
Cardiac muscle cells show decreased contractile response to β-adrenergic stimulation after prolonged norepinephrine exposure. However, direct activation of adenylyl cyclase with forskolin still produces normal cAMP elevation and contractile response. Where in the signaling pathway has desensitization most likely occurred?
Answer: At the β-adrenergic receptor or G-protein coupling level upstream of adenylyl cyclase When you encounter questions about receptor desensitization, think systematically about each step in the signaling cascade to pinpoint where the dysfunction occurs. The key insight here is that forskolin directly activates adenylyl cyclase and still produces normal cAMP elevation and contractile response. This tells you that everything downstream of adenylyl cyclase is functioning properly. Since the pathway works fine when you bypass the receptor and G-protein components, the problem must be upstream of adenylyl cyclase. β-adrenergic receptor desensitization is a well-characterized phenomenon where prolonged norepinephrine exposure leads to receptor phosphorylation, β-arrestin binding, and receptor internalization. This disrupts the coupling between the receptor and its G-protein (Gs), preventing effective signal transduction even though the downstream machinery remains intact. Choice A is incorrect because cAMP-dependent protein kinase activation is working normally—forskolin still produces the expected contractile response. Choice C is wrong for the same reason; the contractile proteins and their cAMP-dependent phosphorylation are functioning since forskolin bypasses the defect. Choice D is incorrect because adenylyl cyclase itself is clearly functional—forskolin directly activates it and produces normal cAMP levels. Remember this pattern: when direct activation of an enzyme downstream still works but natural ligand stimulation fails, look for the problem at the receptor or early coupling steps. This approach helps you quickly identify where in any signaling pathway desensitization or dysfunction has occurred.
A positive feedback mechanism controls oxytocin release during labor, where uterine contractions stimulate more oxytocin release, causing stronger contractions. Which feature distinguishes this from a typical negative feedback system in terms of stability and regulation?
Answer: Positive feedback requires external termination signals, while negative feedback is self-limiting through homeostatic mechanisms When you encounter questions about feedback mechanisms in biology, focus on the fundamental difference in how these systems maintain or disrupt equilibrium. Feedback loops are crucial regulatory mechanisms that determine whether biological processes stabilize around a set point or amplify toward an endpoint. Positive feedback systems like oxytocin release during labor are inherently unstable and amplifying. Each uterine contraction stretches cervical receptors, triggering more oxytocin release, which causes stronger contractions, creating an escalating cycle. This process continues until birth occurs - an external event that terminates the feedback loop. Without this external termination, positive feedback would theoretically continue indefinitely. Negative feedback systems, conversely, are self-regulating and maintain homeostasis. When a variable deviates from its set point, the system responds to counteract that change, automatically returning to equilibrium. Think of a thermostat - it doesn't need external intervention to stop heating once the target temperature is reached. Option A correctly identifies that positive feedback requires external termination while negative feedback is self-limiting through homeostatic mechanisms. Option B incorrectly suggests speed differences are the distinguishing factor - both systems can operate at various speeds. Option C oversimplifies by claiming negative feedback only involves receptor number changes, when it actually uses multiple regulatory mechanisms. Option D incorrectly implies positive feedback bypasses desensitization - both systems use standard cellular signaling pathways. Remember: positive feedback amplifies and needs external stopping signals, while negative feedback self-corrects and maintains stability. This distinction appears frequently on cell biology exams.
A growth factor receptor undergoes autophosphorylation when activated, which recruits adaptor proteins to initiate downstream signaling. However, this phosphorylation also recruits phosphatases that dephosphorylate the receptor. What regulatory principle does this illustrate?
Answer: Built-in negative feedback where receptor activation simultaneously triggers its own inactivation mechanism When analyzing cellular signaling pathways, look for regulatory mechanisms that maintain cellular homeostasis and prevent runaway signaling. This question tests your understanding of how cells build controls into their signaling systems. The scenario describes a classic negative feedback loop. When the growth factor receptor becomes activated and undergoes autophosphorylation, this same phosphorylation event serves a dual purpose: it recruits adaptor proteins that propagate the signal forward, but it also recruits phosphatases that will terminate the signal by removing those same phosphate groups. This creates an elegant self-limiting system where receptor activation automatically initiates its own shutdown mechanism. Answer A describes positive feedback, but that would require the phosphorylation to enhance further receptor activation, not recruit components that terminate signaling. Answer B incorrectly focuses on competitive inhibition between phosphatases and adaptor proteins, but the question indicates both are recruited simultaneously rather than competing for the same binding sites. Answer D misses the regulatory aspect entirely and focuses only on signal amplification, ignoring the phosphatase recruitment that limits the response. This built-in negative feedback (answer C) prevents excessive or prolonged signaling that could be harmful to the cell. It's like having an automatic shutoff valve that activates whenever you turn on the water. Study tip: In cell biology, look for self-regulating mechanisms. Cells rarely have "on" switches without corresponding "off" switches. When you see simultaneous activation of opposing processes, think negative feedback regulation.
In a negative feedback loop controlling thyroid hormone levels, elevated T3 and T4 reduce TSH release from the anterior pituitary. If this feedback mechanism fails due to a pituitary adenoma that secretes TSH independently, which outcome would most likely occur?
Answer: Continuously elevated thyroid hormones leading to hyperthyroid symptoms and thyroid enlargement When you encounter questions about endocrine feedback loops, focus on what happens when the normal regulatory mechanism breaks down. The thyroid axis normally works through negative feedback: high T3/T4 levels signal the pituitary to reduce TSH production, preventing overproduction of thyroid hormones. A pituitary adenoma that secretes TSH independently creates a pathological situation where TSH release becomes uncontrolled and unresponsive to normal feedback signals. Even when T3 and T4 levels rise to dangerous levels, the tumor continues pumping out TSH because it can't "hear" the feedback signals telling it to stop. This continuous TSH stimulation drives the thyroid gland to keep producing more and more hormones. Answer C is correct because this uncontrolled TSH secretion leads to persistently elevated thyroid hormones, causing hyperthyroid symptoms (rapid heart rate, weight loss, anxiety) and thyroid enlargement from constant overstimulation. Answer A is wrong because the thyroid receives excessive stimulation from the tumor's TSH output, not inadequate stimulation. Answer B incorrectly suggests the system can self-correct—but the tumor doesn't respond to feedback, so no oscillation occurs. Answer D assumes hypothalamic compensation can override the tumor's effects, but the hypothalamus can't stop an autonomous adenoma from secreting TSH. Remember that autonomous tumors break normal feedback control—they operate independently of the body's regulatory signals. When you see questions about endocrine tumors, consider how the loss of feedback control affects downstream organs and hormone levels.
A cell continuously exposed to epinephrine for 30 minutes shows a 70% reduction in cAMP response compared to the initial response, despite maintained hormone levels. When epinephrine is removed for 2 hours and then reapplied, the cAMP response recovers to 85% of the original level. Which mechanism most likely explains this pattern?
Answer: Receptor downregulation through endocytosis and degradation of β-adrenergic receptors When you encounter questions about diminished cellular responses over time followed by recovery, think about receptor desensitization mechanisms. This pattern—reduced response during continuous stimulation but recovery after hormone removal—is a hallmark of cellular adaptation to prevent overstimulation. The correct answer is A because receptor downregulation through endocytosis perfectly explains both phases. During continuous epinephrine exposure, β-adrenergic receptors undergo endocytosis and degradation, reducing the number of functional receptors at the cell surface and causing the 70% drop in cAMP response. When epinephrine is removed for 2 hours, the cell synthesizes new receptors and recycles some internalized ones back to the membrane, restoring 85% of the original response capacity. Option B is incorrect because competitive inhibition by cAMP metabolites wouldn't show this recovery pattern—the inhibition would persist even after hormone removal. Option C fails because ATP depletion severe enough to reduce cAMP synthesis by 70% would compromise many other cellular functions, and ATP levels recover within minutes, not requiring 2 hours. Option D is wrong because irreversible modifications, by definition, wouldn't allow the 85% recovery observed after hormone removal. Remember that recovery after stimulus removal is your key clue pointing toward reversible mechanisms like receptor downregulation. Irreversible processes (like covalent modifications) or metabolic issues (like ATP depletion) wouldn't show this characteristic recovery pattern that takes hours to complete.
In a negative feedback loop controlling blood glucose, insulin release reduces glucose levels, which then reduces insulin release. If glucose levels drop too low, glucagon is released to increase glucose. What would happen if the glucagon response were eliminated while maintaining the insulin feedback loop?
Answer: The system would lose the ability to correct for hypoglycemic episodes, creating instability When analyzing feedback systems in physiology, you need to understand how multiple control mechanisms work together to maintain homeostasis. Blood glucose regulation involves both negative feedback (insulin) and counterregulatory mechanisms (glucagon) that respond to different directional changes. The insulin feedback loop can only respond to elevated glucose by promoting glucose uptake and storage. When glucose drops too low, insulin release naturally decreases, but this passive reduction cannot actively raise glucose levels back to normal. Glucagon serves as the active counterregulatory hormone that stimulates glucose production and release from the liver during hypoglycemic episodes. Without glucagon, the system loses its ability to correct downward deviations in blood glucose. While insulin can still respond to high glucose, any factor causing hypoglycemia (missed meals, exercise, medication timing) would create dangerously low glucose levels with no physiological mechanism to restore normal levels. Choice A is incorrect because losing half of a two-part control system doesn't create a new stable set point—it creates instability. Choice C misunderstands insulin's role; increased sensitivity would actually worsen hypoglycemia by making cells remove glucose more efficiently. Choice D incorrectly suggests the system would maintain regulatory capacity with just altered dynamics, when in reality the system loses its ability to respond to one direction of glucose deviation entirely. Remember that effective homeostatic control requires mechanisms that can respond to deviations in both directions from the set point. Single-direction feedback loops create dangerous instability in biological systems.
During prolonged insulin treatment, muscle cells show decreased glucose uptake despite normal insulin levels. Analysis reveals that GLUT4 transporter levels at the plasma membrane are reduced by 60%, while total cellular GLUT4 remains unchanged. What is the most likely underlying mechanism?
Answer: Increased GLUT4 internalization and sequestration in intracellular compartments during desensitization Questions about insulin resistance and glucose transport test your understanding of the cellular mechanisms behind diabetes and metabolic disorders. When you see reduced glucose uptake despite normal insulin levels, focus on the insulin signaling pathway and GLUT4 trafficking. The key clue here is that total cellular GLUT4 remains unchanged while plasma membrane levels drop by 60%. This pattern indicates that GLUT4 proteins are being removed from the membrane and sequestered intracellularly, but they're not being degraded. During prolonged insulin exposure, cells develop insulin resistance through receptor desensitization and altered signaling cascades. The insulin receptors become less responsive, leading to impaired GLUT4 translocation from intracellular storage vesicles to the plasma membrane. This explains why glucose uptake decreases even though GLUT4 proteins still exist within the cell. Option A is wrong because if lysosomal degradation increased, total cellular GLUT4 would decrease, not remain constant. Option B fails because reduced gene expression would also lower total GLUT4 levels, contradicting the data. Option C actually describes the correct mechanism but isn't answer E. Option D incorrectly suggests competitive inhibition, which wouldn't explain the reduced membrane GLUT4 levels. Remember that insulin resistance often involves defects in the signaling cascade rather than complete loss of cellular machinery. When analyzing transport problems, always distinguish between changes in total protein levels versus subcellular localization - this distinction frequently appears on cell biology exams and helps differentiate between synthesis, degradation, and trafficking defects.
In an enzyme cascade where enzyme 1 activates enzyme 2, which activates enzyme 3, the final product inhibits enzyme 1. If enzyme 2 becomes constitutively active due to mutation, how would this affect the feedback regulation of the pathway?
Answer: Feedback control would be partially lost because the pathway can proceed despite enzyme 1 inhibition When you encounter enzyme cascade questions with feedback inhibition, focus on how mutations disrupt the normal regulatory flow. In this pathway, the final product normally inhibits enzyme 1, creating negative feedback that controls the entire cascade's output. The constitutively active enzyme 2 mutation fundamentally breaks this regulatory mechanism. Even when the final product accumulates and inhibits enzyme 1, the pathway can still proceed because enzyme 2 no longer depends on enzyme 1's activation signal. Think of it like a broken switch in a chain of switches - the signal can't be turned off at the beginning because there's now a permanently "on" switch downstream. Answer B correctly identifies that feedback control becomes partially lost. The system loses its ability to shut down the pathway at the normal control point (enzyme 1), allowing continued product formation despite regulatory signals. Answer A is wrong because hyperactivation doesn't enhance regulation - it bypasses it entirely. The regulatory signal becomes ineffective, not amplified. Answer C misunderstands feedback loops. The final product still inhibits enzyme 1 as designed; enzyme 3 doesn't become a new regulatory target just because enzyme 2 is constitutively active. Answer D incorrectly suggests oscillatory behavior. While some biological systems do oscillate, this scenario creates a more straightforward regulatory bypass rather than oscillations. Remember: constitutively active mutations typically disrupt normal regulation by making enzymes unresponsive to their usual controls. Look for how these mutations break the regulatory chain rather than enhance or redirect it.
In a cell culture experiment, cells are treated with a signaling molecule that activates both protein kinase C (PKC) and increases intracellular calcium. Over time, the calcium response diminishes while PKC activity remains elevated. Which mechanism most likely explains this differential desensitization?
Answer: Depletion of endoplasmic reticulum calcium stores through prolonged release without adequate replenishment When you encounter questions about differential responses in cell signaling, focus on the sustainability of the underlying mechanisms and their feedback loops. The key insight here is understanding why calcium levels drop while PKC remains active despite both being triggered by the same initial signal. This points to a limitation in calcium availability rather than signal termination. The endoplasmic reticulum (ER) stores calcium and releases it upon stimulation, but these stores are finite. When calcium is continuously released without sufficient time or mechanisms for replenishment, the ER becomes depleted. This explains why the calcium response diminishes over time - there's simply less calcium available to release. Meanwhile, PKC, once activated, can remain active through other mechanisms and doesn't depend on continuous calcium release. Looking at the incorrect options: Option A suggests PKC inhibits calcium channels, but this would create negative feedback that doesn't match the observed sustained PKC activity. Option B describes calcium buffering by binding proteins, but this would be a rapid response, not a gradual decline over time. Option D proposes increased calcium pump activity, but enhanced extrusion alone wouldn't explain why PKC remains elevated while calcium drops - you'd expect both to be affected if pumps were simply removing calcium faster. Remember that cellular responses often have different kinetics and sustainability. When you see differential desensitization patterns, consider which processes depend on finite resources versus those that can be self-sustaining once initiated.
Sorting an internalized receptor to lysosomes, rather than recycling it, would:
Answer: Lengthen resensitization Sending an internalized receptor to lysosomes marks it for destruction, so fewer receptors are available to return to the membrane. Recovery of normal signaling therefore takes longer, meaning resensitization is lengthened. The tempting choice, accelerating resensitization, confuses lysosomal degradation with recycling, which is what quickly restores surface receptors.
During prolonged stress, cortisol levels remain elevated, but target cells show decreased response to cortisol over time. Analysis reveals that glucocorticoid receptor mRNA levels are reduced by 50% in these cells. Which regulatory mechanism is primarily responsible?
Answer: Negative feedback regulation where cortisol inhibits its own receptor gene transcription When you encounter questions about hormone resistance during prolonged exposure, think about the body's protective mechanisms against overstimulation. Cells have evolved sophisticated ways to prevent damage from excessive hormone signaling. The key insight here is that cortisol receptor mRNA levels are reduced by 50%. This points directly to transcriptional regulation. Cortisol, like many steroid hormones, creates negative feedback loops by binding to glucocorticoid receptors that then act as transcription factors. These activated receptor complexes can bind to regulatory sequences in their own receptor gene and suppress transcription. This is the cell's way of saying "enough" - by making fewer receptors, the cell becomes less sensitive to continued cortisol exposure, protecting itself from potential damage. Option A describes receptor desensitization through phosphorylation, but this affects receptor function without changing mRNA levels. The question specifically mentions reduced mRNA, not altered receptor activity. Option C suggests competitive inhibition by other proteins, which would block receptor function but wouldn't explain the dramatic decrease in receptor gene transcription. Option D discusses receptor saturation, but saturated receptors would still respond maximally to hormone - they wouldn't show the decreased response described in the question. Remember this pattern: when you see reduced mRNA levels for a hormone receptor during chronic hormone exposure, think negative feedback at the transcriptional level. The hormone is literally telling the cell to make fewer of its own receptors.
In a bacterial chemotaxis system, methylation of chemoreceptors occurs during adaptation to constant attractant levels. When attractant concentration suddenly increases, the bacteria tumble less frequently and swim toward higher concentrations. What happens to receptor methylation during this process?
Answer: Methylation gradually increases to restore baseline tumbling frequency despite continued attractant presence When you encounter bacterial chemotaxis questions, focus on understanding that adaptation is a homeostatic mechanism that allows bacteria to detect changes in attractant concentration rather than absolute levels. Here's what happens during chemotaxis adaptation: When attractant concentration suddenly increases, the attractant binds to chemoreceptors, reducing tumbling frequency so bacteria swim toward the source. However, to maintain sensitivity to further concentration changes, the system must "reset" itself through methylation. Methylation of chemoreceptors gradually increases over time, which reduces their sensitivity to the current attractant level. This progressive methylation continues until tumbling frequency returns to baseline levels, even though the attractant is still present. This restoration of normal tumbling behavior is crucial because it allows the bacteria to detect and respond to subsequent concentration changes. Option A incorrectly suggests immediate methylation to enhance sensitivity, but methylation actually decreases sensitivity and occurs gradually, not immediately. Option B describes rapid methylation decrease, which would make receptors hypersensitive rather than restoring baseline behavior - this occurs during demethylation when attractant levels drop. Option D wrongly claims methylation only responds to decreasing attractant levels, but adaptation works in both directions through methylation and demethylation. Remember this key principle for chemotaxis questions: adaptation through methylation isn't about responding to current conditions, but about preparing the system to detect future changes. The goal is always returning to baseline sensitivity for optimal environmental sensing.
During development, a morphogen creates a concentration gradient that specifies cell fate. Cells receiving high morphogen levels express receptor X, while cells receiving low levels express receptor Y. Both receptors bind the same morphogen but trigger opposite cellular responses. What regulatory principle does this illustrate?
Answer: Feedforward control where morphogen concentration determines the type of receptor response system When you encounter questions about morphogens and developmental biology, focus on how concentration gradients create different cellular outcomes through various regulatory mechanisms. This scenario illustrates feedforward control, making C correct. In feedforward regulation, the input signal (morphogen concentration) directly determines which type of response system the cell will use. High morphogen levels trigger cells to express receptor X, while low levels trigger receptor Y expression. The morphogen concentration essentially "feeds forward" to determine not just the strength of the response, but the entire signaling pathway that will be activated. This allows the same morphogen to create completely different cell fates depending on its local concentration. A is incorrect because negative feedback involves the output inhibiting the input - here, morphogen levels determine receptor type, but there's no mention of receptors inhibiting morphogen production. B describes positive feedback where the signal amplifies itself, but the morphogen isn't amplifying its own production through receptor upregulation. D misidentifies the mechanism as competitive inhibition between receptors, but the receptors aren't competing - they're expressed in different cells based on morphogen concentration, and both can bind the morphogen effectively. The key insight is recognizing that the morphogen concentration acts as a "switch" that determines which signaling pathway gets activated, rather than just modulating the intensity of a single pathway. Watch for this pattern in development questions: when the same signal produces opposite outcomes based on concentration, think feedforward control where the signal level determines the response mechanism itself.
A G-protein coupled receptor (GPCR) shows reduced signaling after prolonged agonist exposure. Western blot analysis reveals that total receptor protein levels are unchanged, but the receptor shows increased phosphorylation. Which mechanism is most likely responsible for the reduced signaling?
Answer: Phosphorylation-dependent recruitment of β-arrestins that block G-protein coupling When you encounter GPCR desensitization questions, focus on the temporal sequence of events and what the experimental data tells you. Here, prolonged agonist exposure causes reduced signaling despite unchanged total protein levels, but with increased receptor phosphorylation - this points to a regulatory mechanism that doesn't involve receptor degradation or synthesis. The correct mechanism is phosphorylation-dependent recruitment of β-arrestins that block G-protein coupling (C). After sustained activation, GPCR kinases (GRKs) phosphorylate specific serine/threonine residues on the receptor's intracellular domains. This phosphorylation creates binding sites for β-arrestin proteins, which then bind to the receptor and physically block its interaction with G-proteins, effectively "turning off" the signal while the receptor remains at the cell surface. Option A is incorrect because while phosphorylation can lead to internalization, the question specifies that total protein levels are unchanged, suggesting receptors aren't being removed from the cell. Option B misrepresents the mechanism - phosphorylation doesn't directly reduce G-protein affinity; β-arrestins are the intermediary that blocks this interaction. Option D is wrong because increased phosphorylation in this context affects the intracellular domains involved in G-protein coupling, not the extracellular agonist-binding site. Study tip: Remember the GPCR desensitization hierarchy: phosphorylation → β-arrestin binding → blocked G-protein coupling → potential internalization. The key experimental clue is unchanged total protein with increased phosphorylation, which indicates early-stage desensitization via β-arrestins rather than receptor removal.
In a metabolic pathway, enzyme A converts substrate X to product Y, and enzyme B converts Y to final product Z. Product Z inhibits enzyme A but activates enzyme B. If Z levels become excessive, what will be the immediate effect on pathway flux?
Answer: Pathway flux decreases because enzyme A inhibition creates a bottleneck at the first step When you encounter questions about metabolic pathway regulation, focus on identifying the rate-limiting step and how regulatory molecules affect overall pathway flow. In multi-step pathways, the first enzyme often serves as the primary control point. Let's trace what happens when Z levels become excessive. Since Z inhibits enzyme A (the first step converting X→Y), less substrate X gets converted to Y. This creates an immediate bottleneck right at the pathway's entrance. Even though Z simultaneously activates enzyme B (converting Y→Z), enzyme B can only work with whatever Y is available. If enzyme A is heavily inhibited and produces very little Y, then enzyme B—despite being activated—has insufficient substrate to maintain high flux. The pathway flux is ultimately limited by its slowest step. Answer choice A incorrectly assumes that enzyme B activation can compensate for enzyme A inhibition, but you can't speed up a reaction when there's no substrate available. Choice C suggests the effects balance out, but this ignores that enzyme A's inhibition creates a substrate shortage that enzyme B's activation cannot overcome. Choice D proposes oscillatory behavior, but the question asks for the immediate effect of excessive Z levels, not long-term dynamics. The correct answer is B because enzyme A inhibition creates a bottleneck at the first step, immediately reducing pathway flux regardless of enzyme B's enhanced activity. Remember: in metabolic pathways, the most inhibited step typically becomes rate-limiting. Always identify which enzyme controls substrate entry into the pathway—it's usually the key regulatory point.
Smooth muscle cells in blood vessels show reduced contractile response to norepinephrine after prolonged exposure, but retain normal responses to other vasoconstrictors like angiotensin II. Radioligand binding studies show 40% fewer norepinephrine binding sites. What mechanism explains this selective desensitization?
Answer: Specific downregulation of α-adrenergic receptors while other vasoconstrictor receptors remain normal When you encounter questions about selective drug tolerance or desensitization, focus on whether the effect is specific to one receptor type or affects all cellular responses broadly. The key clues here are "selective desensitization" to norepinephrine while other vasoconstrictors work normally, plus the 40% reduction in norepinephrine binding sites. This scenario demonstrates classic receptor downregulation. Prolonged exposure to norepinephrine causes the smooth muscle cells to internalize and degrade α-adrenergic receptors specifically. With fewer receptors available (40% reduction in binding sites), the cells become less responsive to norepinephrine. Crucially, angiotensin II still works normally because it binds to completely different receptors (AT1 receptors) that weren't affected by norepinephrine exposure. This receptor-specific downregulation is a protective mechanism cells use to prevent overstimulation. Looking at the wrong answers: A) is incorrect because contractile proteins aren't selectively reduced—if they were, all vasoconstrictors would be equally affected. C) misses the mark because calcium store depletion would also impair responses to all vasoconstrictors, not just norepinephrine. D) describes a compensatory mechanism that would counteract all vasoconstriction equally, which contradicts the selective nature of this desensitization. The correct answer is B) because it's the only option explaining selective loss of response to one specific vasoconstrictor while others remain unaffected. Study tip: When you see "selective" desensitization with reduced binding sites, think receptor downregulation. When effects are global, consider downstream problems like calcium handling or contractile machinery.
A cell secretes a protein that blocks its own activating receptor, damping output. This is:
Answer: Negative feedback regulation The secreted protein is the cell's own output, and by blocking its activating receptor it suppresses further signaling, so the pathway dampens itself. That is negative feedback: the product inhibits the process that produces it. The tempting wrong answer is homologous desensitization, but that refers to a receptor becoming less responsive after repeated stimulation, not a secreted protein acting as a feedback inhibitor.

Start this quiz